patricia
luttgen
dvm
ms
enceph
myeliti
mening
term
appli
inflammatori
condit
brain
spinal
cord
mening
respect
close
anatom
proxim
central
nervou
system
cn
structur
inflammatori
process
frequent
involv
one
time
thu
term
encephalomyel
meningoenceph
meningoencephalomyel
may
appli
one
approach
suspect
cn
inflammatori
problem
potenti
becom
widespread
multifoc
diffus
done
alreadi
gener
major
cn
inflammatori
diseas
present
acut
progress
manner
insidi
onset
possibl
fungal
diseas
prove
consist
except
commonli
present
chronic
progress
sign
whenev
rapidli
develop
spread
dysfunct
cn
observ
inflammatori
condit
must
consid
top
list
differenti
diagnos
present
complaint
clinic
sign
seen
inflammatori
diseas
cn
highli
variabl
part
en
suscept
inflammatori
process
etiolog
agent
predisposit
particular
area
cn
canin
distemp
viru
cerebellum
reli
upon
consist
involv
area
case
neurolog
dysfunct
may
focal
multifoc
diffus
natur
rapidli
progress
natur
mani
diseas
initi
focal
local
may
progress
tomultifoc
diffus
rel
short
period
time
predomin
clinic
sign
viral
protozo
parasit
diseas
relat
parenchym
involv
brain
andor
spinal
cord
rickettsi
fungal
diseas
may
display
parenchym
well
mening
sign
bacteri
diseas
commonli
present
mening
sign
may
spread
display
parenchym
sign
although
clinic
sign
highli
variabl
case
enceph
gener
made
sign
usual
reflect
diffus
brain
parenchym
involv
may
slightli
asymmetr
common
clinic
sign
seen
enceph
includ
alter
state
conscious
depress
stupor
forth
behavior
chang
visual
impair
intact
pupillari
light
reflex
incoordin
voluntari
motor
dysfunct
cranial
nerv
dysfunct
sometim
seizur
may
part
histori
myeliti
occur
frequent
associ
enceph
encephalomyel
howev
spinal
cord
parenchyma
may
involv
inflammatori
process
without
associ
brain
involv
clinic
sign
seen
depend
locat
extent
involv
spinal
cord
sign
sensori
ataxia
depress
postur
reaction
motor
dysfunct
possibl
loss
pain
sensat
may
occur
one
limb
urinari
fecal
incontin
may
also
present
classic
two
major
clinic
sign
accompani
mening
neck
pain
fever
afflict
anim
usual
reluct
handl
around
neck
display
cervic
hyperesthesia
muscl
rigid
mening
irrit
may
suffici
caus
opisthotonu
forelimb
hyperextens
gener
hyperesthesia
may
also
present
mening
usual
accompani
degre
parenchym
involv
encephalomyel
mayor
may
clinic
evid
mening
common
diseas
problem
companion
anim
bacteri
mening
organ
gain
access
subarachnoid
space
hematogen
spread
direct
extens
sinus
ear
eye
penetr
trauma
contamin
surgic
instrument
includ
spinal
needl
establish
inflammatori
process
usual
spread
involv
parenchym
structur
meningoencephalomyel
fungal
organ
usual
reach
cn
via
hematogen
lymphat
rout
may
also
arriv
via
direct
extens
adjac
infect
fungal
sinus
rickettsi
organ
infrequ
involv
nervou
system
may
caus
sign
suggest
mening
fever
hyperesthesia
along
sign
parenchym
involv
depress
paresi
seizur
forth
suspect
immunemedi
mening
mening
vasculitisio
also
report
viral
protozo
parasit
diseas
primarili
affect
parenchym
tissu
associ
mening
reaction
clinic
sign
condit
typic
enceph
andor
myeliti
mening
case
suspect
cn
inflammatori
diseas
diagnost
plan
begin
neurolog
minimum
databas
mdb
includ
complet
physic
neurolog
examin
special
attent
paid
ophthalm
otic
examin
addit
electrocardiogram
includ
prepar
anesthesia
necessari
collect
cerebrospin
fluid
csf
laboratori
test
includ
complet
blood
count
cbc
blood
chemistri
profil
includ
electrolyt
urinalysi
fecal
analysi
choic
addit
laboratori
test
base
mdb
result
laboratori
test
mdb
evalu
gener
health
anim
includ
nervou
system
multisystem
involv
often
reflect
abnorm
physic
laboratori
find
know
organ
system
prefer
variou
etiolog
agent
help
clinician
formul
reason
differenti
list
base
mdb
abnorm
well
identifi
addit
tissu
possibl
cultur
mani
anim
inflammatori
process
extend
outsid
cn
case
unusu
mdb
laboratori
result
total
normal
nervou
system
effect
isol
organ
system
bloodbrain
bloodcsf
csfextracellular
fluid
bloodey
bloodnerv
barrier
even
though
normal
assum
barrier
compromis
cn
inflammatori
process
mean
diseas
process
reflect
mdb
laboratori
result
experi
anim
primari
cn
inflammatori
diseas
usual
normal
mdb
laboratori
result
notabl
except
felin
infecti
periton
fip
requir
addit
diagnost
test
make
diagnosi
ophthalm
otic
examin
opthalm
otic
examin
especi
import
suspect
case
cn
inflammatori
diseas
optic
nerv
extend
directli
brain
papilledema
optic
neuriti
may
reflect
larger
inflammatori
process
cn
mani
organ
caus
cn
inflamm
also
caus
ocular
lesion
evid
acut
chorioretin
granulomat
chorioretin
vascul
retin
hemorrhag
retin
detach
uveiti
corneal
edema
kerat
conjunct
assist
greatli
rule
possibl
etiolog
ear
one
common
site
entri
organ
cn
otiti
externa
extrem
common
dog
extend
becom
otiti
medialinterna
subsequ
invas
cn
oropharyng
inflamm
may
also
extend
caus
otiti
medialinterna
sign
otiti
investig
thoroughli
anim
display
cn
inflammatori
diseas
cerebrospin
fluid
analysi
singl
import
diagnost
test
perform
anim
suspect
cn
inflammatori
diseas
even
possibl
falseneg
result
mislead
cellular
popul
great
caution
must
exercis
collect
fluid
potenti
danger
anesthesia
tentori
herniat
spread
infect
risk
csf
collect
collect
csf
companion
anim
requir
gener
anesthet
restraint
alway
entail
risk
anim
enceph
risk
compound
potenti
involv
respiratori
center
brain
stem
reticular
activ
system
encephalit
anim
often
present
alreadi
alter
state
conscious
therefor
much
suscept
anesthet
accid
great
care
must
taken
administ
monitor
anesthesia
anim
enceph
enceph
caus
cerebr
edema
lead
increas
intracrani
pressur
csf
remov
ventricular
volum
thu
intracrani
pressur
reduc
allow
parenchyma
swell
intracrani
pressur
suffici
increas
csf
remov
cerebr
hemispher
cerebellum
move
caudal
tentorium
cerebelli
foramen
magnum
respect
caus
midbrain
medullari
brainstem
compress
lifethreaten
condit
unless
correct
immedi
clinic
sign
suggest
increas
intracrani
pressur
includ
alter
mentat
alter
pupillari
size
respons
poor
absent
eye
movement
respons
alter
head
posit
physiolog
vestibular
nystagmu
motor
dysfunct
abnorm
respiratori
pattern
increas
intracrani
pressur
suspect
csf
collect
delay
attempt
made
therapeut
reduc
pressur
drug
prove
help
reduc
cerebr
edema
osmot
diuret
ghlcocorticoid
gener
contraind
cn
inflammatori
diseas
dimethylsulfoxid
barbitur
nonsteroid
analges
antifibrinolyt
agent
antibiogen
amin
compound
endorphin
antagonist
blood
flow
stimul
drug
advoc
tentori
herniat
suspect
improv
clinic
sign
indic
respons
therapi
time
decis
csf
collect
made
fortun
case
inflammatori
cn
diseas
intracrani
pressur
elev
significantli
enough
prevent
collect
analysi
ofcsf
collect
csf
may
hasten
spread
inflammatori
process
alter
csf
flow
dynam
csf
collect
fluid
withdrawn
rate
faster
normal
flow
rate
csf
ventricl
subarachnoid
space
central
spinal
canal
caus
agent
present
csf
movement
cn
may
hasten
also
mening
may
becom
contamin
secondari
spinal
tap
csf
collect
csf
commonli
collect
cisterna
magna
cerebellomedullari
cistern
provid
largest
easili
access
reservoir
csf
companion
anim
even
care
must
exercis
placement
spinal
needl
punctur
medullari
brain
stem
may
occur
caus
death
subsequ
respiratori
failur
fluid
withdrawn
rapidli
froip
cisterna
tentori
herniat
may
occur
advis
rate
remov
faster
ml
per
interv
lumbar
subarachnoid
punctur
extrem
difficult
perform
often
yield
adequ
volum
analysi
addit
csf
collect
lumbar
subarachnoid
space
shown
differ
protein
cellular
content
fluid
collect
cisterna
magna
could
complic
interpret
collect
csf
alway
perform
asept
manner
sternal
later
posit
anim
determin
person
prefer
fluid
aspir
syring
drip
collect
prefer
anim
need
pla
later
recumb
twentyoneor
style
ted
spinal
needl
adequ
use
largests
dog
occasion
needl
necessari
giant
breed
extrem
small
anim
butterfli
needl
attach
tube
use
assist
avail
aspir
fluid
csf
analysi
interpret
routin
csf
analyz
color
turbid
protein
content
total
red
rbc
white
blood
cell
wbc
count
differenti
cell
count
addit
wise
tri
cultur
csf
bacteri
fungal
etiolog
suspect
organ
seen
cytolog
examin
gener
elev
protein
content
wbc
count
seen
cn
inflammatori
diseas
increas
vari
type
organ
involv
durat
inflammatori
process
mening
involv
seem
caus
greater
increas
protein
cell
count
pure
parenchym
involv
protein
content
viral
diseas
seem
caus
least
amount
protein
elev
except
fip
viru
caus
mark
increas
protein
cell
chang
viral
diseas
gener
caus
slight
moder
pleocytosi
wbc
per
mm
primarili
mononuclear
lymphocyt
macrophag
natur
collect
acut
stage
viral
diseas
howev
csf
may
neutrophil
pleocytosi
appear
like
bacteri
mening
felin
infecti
periton
prove
gener
except
routin
display
moder
mark
elev
mix
popul
wbc
includ
signific
number
neutrophil
bacteri
infect
caus
dramat
elev
wbc
high
percentag
wbc
neutrophil
earli
inflammatori
process
diseas
progress
mix
popul
neutrophil
mononuclear
cell
primarili
macrophag
may
seen
fungal
diseas
commonli
present
moder
mark
elev
mix
popul
mononuclear
polymorphonuclear
cellsio
protozo
diseas
usual
present
moder
pleocytosi
mix
mononuclear
polymorphonuclear
cell
parasit
diseas
display
moder
mark
mix
mononuclearpolymorphonuclear
pleocytosi
often
signific
percentag
eosinophil
rickettsi
diseas
report
normal
markedli
increas
cell
count
cell
report
mainli
mononuclear
natur
howev
one
report
rmsf
great
number
neutrophil
per
cent
present
eosinophil
pleocytosi
report
human
granulomat
meningoenceph
usual
moder
mark
number
mononuclear
cell
lymphocyt
monocyt
macrophag
present
csf
cultur
cultur
csf
difficult
often
unreward
even
organ
seen
cytolog
examin
enrich
media
special
incub
techniqu
usual
requir
success
cultur
csf
attempt
cultur
csf
probabl
reserv
case
increas
protein
content
neutrophil
pleocytosi
suspect
bacteri
involv
frequenc
falseneg
csf
cultur
result
rapidli
progress
cours
bacteri
mening
antimicrobi
therapi
delay
pend
cultur
sensit
result
meningoencephalomyel
aris
secondari
hematogen
spread
organ
organ
system
infect
bacteri
endocard
urinari
tract
infect
asept
obtain
blood
urin
tissu
sampl
indic
tracheal
wash
lung
aspir
cultur
often
provid
definit
inform
caus
meningoencephalomyel
csf
cultur
advis
collect
sampl
time
csf
collect
hope
identifi
organ
rapidli
possibl
thu
expedi
correct
antimicrobi
therapi
serolog
test
exist
brucella
cani
canin
distemp
viru
cov
fip
toxoplasmosi
rickettsi
organ
fungal
organ
experi
fip
toxoplasmosi
fungal
titer
extrem
unreli
date
rickettsi
titer
univers
illinoi
univers
georgiat
laboratori
prove
reliabl
help
serolog
test
brucella
cani
coy
number
test
avail
brucella
cani
sensit
other
falseposit
falseneg
result
possibl
depend
test
use
reason
two
test
often
perform
make
final
determin
test
result
alway
interpret
light
clinic
find
canin
distemp
viru
titer
perform
serum
csf
simultan
serum
may
increas
anticoy
antibodi
vaccin
natur
infect
antibodi
produc
local
increas
csf
anticoy
antibodi
appear
week
onset
diseas
occur
cov
enceph
provid
definit
evid
viru
present
cn
increas
csf
anticov
antibodi
demonstr
vaccin
dog
dog
system
diseas
without
cn
involv
blood
contamin
may
artifici
increas
anticoy
titer
csf
suspect
time
collect
csf
analysi
laboratori
auburn
univers
provid
reliabl
result
experi
otiti
internalmedia
suspect
caus
meningoenceph
skull
film
tympan
bulla
may
help
make
diagnosi
sclerosi
lysi
osseou
bulla
increas
densiti
bulla
caviti
asymmetri
bulla
would
suggest
otiti
internalmedia
meningoenceph
suspect
secondari
cranial
trauma
skull
radiograph
may
help
confirm
diagnosi
electroencephalographi
eeg
extrem
help
diagnost
test
cn
inflammatori
diseas
find
may
abnorm
nonspecif
assist
identif
caus
agent
select
therapeut
protocol
predict
outcom
ear
cultur
otiti
internalmedia
suspect
sourc
etiolog
agent
meningoenceph
cultur
middl
ear
may
help
extrem
difficult
obtain
without
secondari
contamin
may
prove
help
select
correct
antimicrobi
therapi
fluoresc
antibodi
test
cdv
perform
time
clinic
infect
appar
test
help
confirm
presenc
coy
result
usual
neg
recoveri
stage
begin
may
even
neg
infect
stage
consequ
neg
result
use
rule
coy
antimicrobi
agent
ideal
select
base
specif
action
caus
organ
bactericid
tendenc
access
site
infect
rapid
action
lack
undesir
side
elfect
deal
cn
inflammatori
diseas
access
becom
critic
problem
owe
natur
barrier
primarili
bloodbrain
bloodcsf
passag
drug
cn
orug
low
degre
ioniz
low
degre
plasma
protein
bind
high
degre
lipid
solubl
union
state
favor
enter
cn
increas
membran
solubl
addit
inflammatori
damag
may
dr
larri
swango
depart
microbiolog
auburn
univers
colleg
veterinari
medicin
auburn
alabama
increas
cn
concentr
drug
increas
membran
permeabl
drug
slow
remov
csf
tabl
bacteri
infect
bacteri
infect
cn
rapidli
progress
fatal
treat
aggress
bacteri
infect
suspect
antibiot
therapi
start
immedi
chang
made
later
base
cultur
result
lack
respons
therapi
highdos
intraven
bactericid
therapi
prefer
obtain
highest
csf
concentr
efficaci
drug
rapidli
possibl
bactericid
bacteriostat
drug
combin
reduc
efficaci
commonli
report
organ
cal
sing
bacteri
meningoencephalomyel
companion
anim
staphylococcu
aureu
staphylococcu
epidermidi
staphylococcu
albu
pasteurella
multocida
pasteurella
speci
actinomyc
speci
nocardia
speci
initi
therapi
begin
assumpt
staphylococcu
like
caus
high
dose
intraven
iv
penicillin
g
u
per
kg
everi
hour
iv
ampicillin
mg
per
kg
everi
hour
oral
po
amoxicillin
mg
per
kg
everi
hour
recommend
ampicillin
amoxicillin
prefer
penicillin
g
broader
spectrum
activ
caus
organ
prove
coagulaseposit
staphylococcu
medic
chang
methicillin
oxacillin
use
penicillinresist
staphylococci
carbenicillin
drug
choic
pseudomona
infect
tempt
begin
therapi
chloramphenicol
believ
high
concentr
achiev
csf
overcom
disadvantag
bacteriostat
howev
mani
strain
staphylococcu
shown
resist
drug
demonstr
poor
efficaci
gramneg
organ
probabl
best
use
chloramphenicol
organ
determin
sensit
secondchoic
drug
chloramphenicol
md
penicillin
antagonist
use
simultan
unless
deem
absolut
necessari
use
togeth
penicillin
administr
preced
chloramphenicol
least
hour
trimethoprimsulfonamid
combin
bactericid
drug
penetr
cn
barrier
well
togeth
rel
broad
spectrum
activ
combin
kept
mind
initi
treatment
seem
effect
metronidazol
mg
per
kg
oral
everi
hour
penetr
cn
well
effect
anaerob
organ
penicillin
carbenicillin
probabl
commonli
use
cn
anaerob
infect
metronidazol
prove
effect
rifampin
isonizid
antituberculosi
mycobacterium
tuberculosi
drug
reach
signific
level
csf
rifampin
mg
per
kg
oral
everi
hour
addit
activ
staphylococcu
gramneg
bacteria
shown
enhanc
antifung
effect
amphotericin
b
aminoglycosid
penicillin
synergist
combin
howev
amino
glycosid
penetr
cn
poor
justif
use
bacteri
meningoencephalomyel
treat
noncn
sourc
infect
intrathec
administr
gentamicin
everi
hour
advoc
overcom
cn
barrier
howev
disadvantag
approach
probabl
outweigh
advantag
major
case
gener
tetracyclin
use
treatment
en
inflamm
penetr
poorli
bacteriostat
limit
spectrum
howev
newer
lipidsolubl
secondgener
tetracyclin
minocyclin
doxycyclin
penetr
cn
better
activ
anaerob
certain
aerob
organ
minocyclin
combin
streptomycin
prove
effect
brucella
cani
infect
gener
cephalosporin
penetr
cn
howev
conflict
report
abil
rel
toxic
firstgener
cephalosporin
cephaloridin
cephalothin
cephalexin
enter
cn
time
inflamm
cephalexin
prove
success
staphylococcu
aureu
mening
one
report
second
cefamandol
cefoxitin
thirdgener
cefotaxim
moxalactam
cephalosporin
shown
penetr
csf
suffici
level
kill
organ
encount
howev
drug
demonstr
variabl
success
clinic
set
achiev
highest
possibl
csf
level
rapidli
possibl
highdos
antibiot
therapi
administ
iv
possibl
week
follow
oral
medic
antibiot
therapi
continu
least
week
treatment
success
often
longer
period
administr
requir
relaps
possibl
glucocorticoid
combin
antibiot
recommend
reduc
tissu
inflammatori
respons
case
meningoenceph
difficulti
get
microcid
level
antimicrobi
cn
success
treatment
bacteri
fungal
meningoenceph
depend
great
deal
bodi
abil
mobil
natur
defens
mechan
assist
remov
caus
agent
dose
glucocorticoid
suffici
reduc
cerebr
edema
immunosuppress
associ
increas
morbid
mortal
relaps
author
agre
osmot
diuret
use
instead
glucocorticoid
cerebr
edema
deem
signific
enough
requir
treatment
fungal
infect
central
nervou
system
fungal
infect
difficult
usual
unreward
treat
diseas
often
multisystem
seldom
recogn
earli
stage
cn
involv
combin
antimicrobi
agent
seem
efficaci
individu
drug
therapi
amphotericin
b
flucytosin
ketoconazol
main
agent
use
none
penetr
cn
well
rifampin
penetr
cn
shown
enhanc
amphotericin
b
activ
therapeut
regimen
begin
amphotericin
b
mg
per
kg
iv
everi
day
mg
per
kg
gradual
increas
mg
per
kg
time
weekli
total
dose
mg
per
kg
add
flucytosin
ketoconazol
intrathec
amphotericin
b
mg
everi
day
total
mg
advoc
increas
concentr
drug
csf
flucytosin
amphotericin
b
act
synergist
vitro
cryptococcu
neoforman
combin
scfem
good
effect
case
coccidioidomycosi
probabl
iv
amphotericin
b
reach
high
enough
level
effect
therefor
amphotericin
b
recommend
coccidioid
immiti
infect
ketoconazol
may
effect
candida
speci
coccidioid
immiti
histoplamsa
capsulatum
cryptococcu
neoforman
penetr
cn
poorli
use
probabl
benefici
system
rather
cn
fungal
involv
rifampin
comqin
amphotericin
b
seem
help
histoplasmacapsulatum
none
drug
work
well
aspergillu
speci
amphotericin
b
combin
flucytosin
rifampin
tri
newergener
imidazol
current
investig
appear
reach
signific
level
csf
inflamm
approv
drug
may
offer
new
hope
treatment
fungal
meningoencephalomyel
viral
infect
effect
treatment
known
viral
nervou
system
diseas
best
offer
good
nurs
care
support
secondari
bacteri
invad
glucocorticosteroid
may
lessen
clinic
sign
also
suppress
natur
defens
mechan
bodi
mechan
overcom
viral
infect
antivir
drug
great
interest
date
prove
quit
toxic
given
system
virus
seem
suscept
replic
usual
occur
time
diagnosi
made
gener
drug
current
practic
use
viral
diseas
companion
anim
treatment
attempt
case
rabi
pseudorabi
risk
public
health
megados
vitamin
intraven
modifi
live
vaccin
prove
benefici
case
canin
immunosuppress
drug
glucocorticoid
melphan
cytoxan
use
cat
fip
poor
longterm
result
iricreas
environment
temperatur
puppi
afflict
neonat
canin
herpesviru
may
lower
mortal
llo
meningoenceph
caus
canin
parainfluenza
viru
report
clinic
experiment
import
canin
parainfluenza
viru
natur
occur
neurolog
disord
remain
determin
treatment
current
known
parvoviru
coronavirusparvoviru
vaccin
incrimin
caus
neurolog
dysfunct
puppi
sign
meningoenceph
seen
four
puppi
shortli
diagnosi
parvoviru
enter
parvoviru
isol
brain
puppi
die
sever
necrot
vascul
encephalomalacia
without
clinic
sign
enter
eight
puppi
report
neurolog
sign
follow
vaccin
canin
coronavirusparvoviru
vaccin
report
treatment
describ
puppi
die
rickettsi
infect
ehrlichiosi
ehrlichia
cani
rocki
mountain
spot
fever
rickettsia
rickettsii
salmon
poison
diseas
neorickettsia
helminthoeca
report
caus
enceph
companion
anim
howev
diseas
commonli
associ
clinic
sign
pyrexia
petechi
anemia
lymphadenopathi
splenomegali
lyme
diseas
borrelia
burgdorferi
identifi
anim
limb
joint
disord
clinic
sign
report
dog
neurolog
involv
report
human
be
watch
anim
tetracyclin
chloramphenicol
shown
effect
rickettsi
organ
bacteriostat
elimin
organ
bodi
depend
immunocompet
anim
use
chloramphenicol
advis
anem
anim
prefer
young
dog
avoid
tetracyclin
stain
teeth
support
therapi
vari
among
individu
case
may
includ
fresh
blood
plateletrich
plasma
transfus
bone
marrow
stimul
fluid
therapi
appetit
stimul
doxycyclin
prove
effect
oxytetracyclin
treatment
ehrlichiosi
lipidsolubl
tetracyclin
doxycyclin
better
penetr
cn
prefer
case
cn
involv
protozo
infect
protozo
infect
cn
rare
companion
anim
toxoplasmosi
babesiosi
encephalitozoonosi
trypanosomiasi
ameb
meningoenceph
report
treatment
condit
variabl
result
gener
guard
poor
prognosi
pyrimethamin
sulfadiazin
combin
effect
cn
toxoplasmosi
trimethoprimsulfonamid
folin
acid
simultan
administ
combt
pyrimethamineinduc
bone
marrow
suppress
medic
use
treat
system
toxoplasmosi
limit
effect
chloramphenicol
penetr
cn
well
tetracyclin
clindamycin
imidocarb
dipropion
diminazen
acetur
phenamidin
isethion
aromat
diamidin
suggest
canin
babesiosi
imidocarb
dipropion
also
effect
ehrlichia
cani
two
intramuscular
inject
mg
per
kg
imidocarb
dipropion
given
day
apart
seem
effect
babesia
cani
ehrlichia
cani
drug
complet
success
clear
babesia
gibsoni
singl
dose
primaquin
phosphat
intramuscularli
mg
per
kg
recommend
felin
babesiosi
babesia
feli
lithium
antimoni
thiomal
nifurtimox
mg
per
kg
per
day
oral
month
recommend
treatment
trypanosomiasi
treatment
exist
encephalitozoonosi
acanthamoeba
castellani
diagnos
histopatholog
immunosuppress
puppi
rapidli
fulmin
meningoenceph
acanthamoeba
speci
also
report
caus
meningoenceph
human
be
parasit
infect
parasit
rare
caus
cn
damag
companion
anim
dirofilaria
immiti
cuterebra
larva
frequent
report
parasit
involv
suspect
pleocyt
csf
present
high
percentag
eosinophil
dirofilaria
immiti
may
suspect
blood
test
posit
definit
test
presenc
cuterebra
larva
condit
usual
diagnos
postmortem
examin
therefor
success
treatment
rare
describ
success
surgic
remov
extramedullari
larva
possibl
suspect
confirm
parasit
infect
cn
report
cat
acut
neurolog
sign
csf
eosinophil
pleocytosi
report
recov
follow
therapi
confirmatori
diagnosi
etiolog
could
made
granulomat
encephalomyel
caus
angiostrongylu
cantonensi
report
puppi
trypanosoma
evansi
confirm
caus
meningoenceph
dog
protothecaiinfect
protothecosi
extrem
rare
caus
cn
inflamm
companion
anim
success
treatment
report
multisystem
polyarter
necrot
vascul
involv
mening
report
dog
display
clinic
sign
characterist
mening
pyrexia
pain
cervic
rigid
major
dog
rel
young
anim
two
report
relat
dog
involv
csf
reveal
neutrophil
pleocytosi
elev
protein
content
peripher
neutrophilia
present
steroid
use
dog
caus
transient
longlast
improv
organ
identifi
author
suspect
immunemedi
caus
vascul
two
report
young
dog
corticosteroidrespons
mening
parallel
clinic
laboratori
find
report
case
confirm
polyarter
one
dog
underw
patholog
examin
month
intermitt
steroid
administr
chronic
activ
suppur
leptomening
leptomening
fibrosi
report
noth
specif
said
mening
vessel
immun
mechan
suspect
dog
numer
case
nonsuppur
inflammatori
diseas
focal
diffus
cn
lesion
report
rare
ocular
involv
also
report
term
reticulosi
formerli
use
describ
call
dissemin
gme
inflammatori
reticulosi
focal
gme
neoplast
reticulosi
ocular
gme
ocular
reticulosi
clinic
sign
reflect
focal
multifoc
diffus
natur
cn
involv
focal
gme
commonli
involv
brain
stem
wherea
dissemin
gme
usual
widespread
especi
cerebrum
lower
brain
stem
cerebellum
cervic
cord
caus
unknown
immunolog
basi
suspect
signal
nonspecif
clinic
sign
acut
chronic
progress
vari
site
cn
involv
csf
mild
moder
mg
per
dl
elev
protein
moder
mark
wbc
per
mm
mononuclear
pleocytosi
lymphocyt
monocyt
macrophag
temporari
clinic
improv
may
seen
glucocorticoid
therapi
effect
treatment
known
chronic
progress
syndrom
ataxia
paresi
tremor
pupillari
abnorm
seizur
report
cat
vari
breed
age
patholog
suggest
viral
caus
organ
could
demonstr
lesion
similar
lesion
report
lion
tiger
viral
caus
also
suspect
never
confirm
similar
case
report
chronic
progress
granulomat
meningoenceph
caus
diffus
degener
white
matter
less
often
gray
matter
report
pug
dog
month
year
age
clinic
sign
predominantli
relat
cerebr
lesion
gener
seizur
ataxia
paresi
circl
depress
partial
motor
seizur
visual
deficit
intact
pupillari
reflex
central
vestibular
cerebellar
spinal
cord
sign
also
report
death
usual
preced
statu
epilepticu
cerebrospin
fluid
show
elev
protein
content
moder
elev
lymphocyt
mononuclear
cell
viral
isol
unsuccess
leav
etiolog
unknown
famili
predisposit
warrant
investig
specif
treatment
known
seizur
often
refractori
anticonvuls
corticosteroid
prove
help
cat
neurolog
sign
includ
disorient
inabl
stand
visual
hear
loss
seizur
display
mild
csf
pleocytosi
wbc
per
mm
per
cent
eosinophil
mild
elev
csf
protein
mg
per
dl
caus
suspect
type
hypersensit
reaction
cat
success
treat
wtih
dexamethason
prognosi
diagnost
find
cn
inflammatori
diseas
may
vari
wide
differ
anim
affect
etiolog
agent
often
make
diagnosi
choic
therapi
extrem
difficult
mani
diseas
posit
confirm
patholog
examin
prognosi
cn
inflammatori
diseas
must
consid
guard
poor
even
seem
respons
therapi
temporari
remiss
relaps
common
inflammatori
diseas
involv
central
nervou
system
difficult
diagnos
frustrat
treat
clinician
maxim
success
treatment
patient
recogn
clinic
sign
earli
stage
diseas
follow
logic
diagnost
plan
identifi
specif
etiolog
agent
involv
formul
appropri
aggress
therapeut
plan
treatment
alway
success
owe
lack
effect
treatment
irrevers
neurolqg
damag
